137 related articles for article (PubMed ID: 170227)
1. Narcotic antagonists: a reasonable method of treating narcotic dependency.
Schooff KG; Hersch RG; Keegan JF
Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227
[TBL] [Abstract][Full Text] [Related]
2. A controlled study using cyclazocine in the treatment of narcotic addiction.
Chappel JN; Jaffe JH; Senay EC
Am J Drug Alcohol Abuse; 1974; 1(2):233-42. PubMed ID: 4619540
[No Abstract] [Full Text] [Related]
3. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
4. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
[No Abstract] [Full Text] [Related]
5. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
[No Abstract] [Full Text] [Related]
6. Antagonist study in St. Louis.
Parwatikar S; Crawford J; Unverdi C
Am J Drug Alcohol Abuse; 1975; 2(3-4):379-90. PubMed ID: 1227299
[No Abstract] [Full Text] [Related]
7. A new antagonist treatment program for narcotic addicts (the first Antagonist-Inmate Work Release Program).
Brahen LS; Capone T; Wiechert V
Proc Natl Conf Methadone Treat; 1973; 1():401-4. PubMed ID: 4808175
[No Abstract] [Full Text] [Related]
8. Cyclazocine and methadone in narcotic addiction.
Freedman AM; Fink M; Sharoff R; Zaks A
JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
[No Abstract] [Full Text] [Related]
9. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
10. High-dose cyclazocine therapy of opiate dependence.
Resnick R; Fink M; Freedman AM
Am J Psychiatry; 1974 May; 131(5):595-7. PubMed ID: 4594561
[No Abstract] [Full Text] [Related]
11. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
12. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
13. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
14. Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Resnick RB; Volavka J; Freedman AM; Thomas M
Am J Psychiatry; 1974 Jun; 131(6):646-50. PubMed ID: 4827793
[No Abstract] [Full Text] [Related]
15. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
16. Prospects, problems, side effects, and safety of narcotic antagonists.
Resnick RB
Int J Addict; 1977 Oct; 12(7):863-7. PubMed ID: 591144
[TBL] [Abstract][Full Text] [Related]
17. The use of cyclazocine in the treatment of heroin addicts.
Petursson ES; Preble E
Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792
[No Abstract] [Full Text] [Related]
18. Cyclazocine treatment for heroin addicts.
Kissin B; Ottomanelli G; Sang E; Halloran G
Proc Natl Conf Methadone Treat; 1973; 1():658-66. PubMed ID: 4808217
[No Abstract] [Full Text] [Related]
19. Analysis and modification of opiate reinforcement.
Meyer RE; McNamee HB; Mirin SM; Altman JL
Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
[TBL] [Abstract][Full Text] [Related]
20. Antagonist Inmate Work-Release Program behavioral research design.
Capone T; Brahen LS; Wiechert V
Proc Natl Conf Methadone Treat; 1973; 1():405-10. PubMed ID: 4808176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
